Newtogahome 10mg (Lafutidine)

Adult dose

1. Short-term treatment of gastric ulcers: The usual dose of lafutidine is 10mg orally twice daily, in the morning and at bedtime. In clinical trials in which it was administered for up to 8 weeks, most ulcers healed within 8 weeks, although healing time may vary among patients. 2. Short-term treatment of duodenal ulcers: The usual dose of lafutidine is 10mg orally twice daily, in the morning and at bedtime. In clinical trials in which it was administered for up to 6 weeks, most ulcers healed within 6 weeks, although healing time may vary among patients. 3. Improvement of gastric mucosal lesions in acute and chronic gastritis: The usual dose of lafutidine is 10mg orally once daily at bedtime. In clinical trials in which it was administered for up to 2 weeks, most lesions healed within 2 weeks, although healing time may vary among patients. 4. Combination therapy with antibiotics in patients with peptic ulcers infected with Helicobacter pylori: Administer lafutidine 20mg, clarithromycin 500mg, and amoxicillin 1000mg twice daily for 7 or 14 days. 5. Premedication for anesthesia: The usual dose of lafutidine is 10mg per dose, administered orally twice (at bedtime on the day before surgery and 2 hours before anesthesia on the day of surgery). 6. Treatment of reflux esophagitis: Administer lafutidine 10mg per dose orally twice daily.

This drug should not be used by patients who are allergic to its ingredients. Additionally, this drug contains lactose, so patients with a genetic disorder that prevents lactose digestion should not take it. Patients who have experienced an allergic reaction to the medication previously, those with liver or kidney problems, patients undergoing dialysis, and the elderly should use this drug cautiously. During use, severe allergic reactions, liver function impairment, and reduction in blood cell counts may occur, so careful observation is necessary. This drug may mask symptoms of malignant tumors such as gastric cancer; any unintended weight loss or recurrent vomiting must be evaluated. Elderly patients may have decreased physical function, thus dosage and intervals should be carefully monitored. Dialysis patients with decreased kidney function may retain more of the drug in their body, hence they should start with a low dose. Pregnant women or women who may become pregnant should only use it when deemed necessary by a doctor, and it is advisable for nursing mothers to avoid this drug. Safety in children has not been well established, so it should be used cautiously in pediatric patients. This drug should be stored out of reach of children, kept in its original container, as transferring to another container could lead to misuse or quality degradation.

• Shock
• anaphylaxis symptoms
• facial pallor
• hypotension
• generalized rash
• dyspnea
• liver dysfunction
• jaundice
• agranulocytosis
• pharyngitis

This drug should be stored in a tightly closed container to protect it from air and moisture. It is important to maintain storage temperature at room temperature between 1°C and 30°C. This will help maintain the efficacy of the drug for a longer period.

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle